Investment Q&A

Q: I am looking for a health care ETF. Right now I am looking at ZHU and XHC. One is global and one is US focused.
ZUH has a MER of 0.39 and a yield of 0.42.
While XHC has a MER of 0.65 but a yield of 1.49.Which I think cancels out the higher MER.

I am not sure which one is right for me or how to choose. Could I use growth potential? Does one have more growth potential than the other? Or what other factors could I use to help me decide?

Q: Hi 5I,

As when anything goes wrong in a specific industry such as HCG and mortgages, many companies may be tarred with the same brush. Is there any company that has fallen just being in the same space as HCG that may be a good under valuation buy? Thank-you

Q: Hi,
Are robo-advisors safe to invest with? Are there any government insurance protections?I am thinking to set up an RESP a/c for my grandson.

Q: Please advice best stocks to buy today in consumer sector and healthcare?.

Q: EQB is dropping in sympathy with HCG, what is your opinion on it?

Q: Greetings 5i,

Looking to further enhance geographical diversification in my overall portfolio. I have fairly balanced exposure to NA, about 8% Europe, but only 1% Asia so I am looking to bring up my exposure in that region. My question is regarding exposure to India specifically. I wish to dollar cost average into this geographical region therefore I have been looking for a mutual fund rather than an ETF due to cost prohibitive transaction fees of $9.99 with my institution. What are your thoughts on Excel India Series D fund (EXL770)? I have it as No load, Mer 1.75, Min $250 and subsequent $50. Im open to suggestions and or direction keeping in mind the dollar cost averaging is preferred to me over a big initial commitment to a geographical region like this.

Cheers!

Q: This is related to HCG. Investors are pulling their deposits out of Home Capital. How concerned should I be as I have deposits with EQ bank and Achieva. Do they (and others offering high deposit rates) fall in the same 'concern' bracket? Each is under $100k so are covered by CDIC.

Q: Sorry to continue to beat this on the head...agreed that the Q1 2016 and Q1 2017 are an apples to oranges comparison. But if the company has 1/2 the net earnings Q1 2017 vs Q1 2016 is that not a worry that the company is very overpriced?

Thanks,
Dave

Q: Could you give a list of 5i's portfolio holdings that you consider provides a significant (partial) substitute for direct U.S. or International investment choices, along with a rough percentage of how much of each holding you feel would qualify for our "non-Canadian" portion ? Many thanks.

Q: Peter; Is there a ETF or other option to buy the CAD ? Thanks. Rod

Q: Do you know if there is already any shot activity on Shopify ? or any threat of such action.

Would Shopify be a suitable candidate for a "short attack"

Q: Good day

I will like your assistance on guiding my investment decision. I have read your report on Knight Therapeutics. After Knight has deployed its war chest($736,000,000), you are forecasting earnings per share of $0.59, plus the EPS for the last quarterly report of 0.06$. If earnings grow at 15% per year for the next 5 years, then in 2022, EPS will be :

2017 2018 2019 2020 2021 2022

$0.65 $0.75 $0.86 $0.99 $1.14 $1.31

I am assuming cash is deployed this year, the share count remains constant and investors in 2022 are willing to pay 15 times EPS. If this scenario holds, then in 2022, the share price should trade at around $20 (1.31 X 15). At current price ($10.60), this scenario would result in an annual rate of return for the next five years of 13.1%. Are you comfortable with my scenario or would you change some of my parameters ?

Gilles

Q: I own some Home Trust notes ( due May17 and Dec18). Are these at risk? Why has the price dropped if they
are due in only a few weeks, is this a bond market looking to take advantage of fear?

Q: Hi, Could you please provide quarterly estimates for Rev, EBITDA and Adj EPS for KXS and SHOP. Thanks

Q: Is there any disadvantage to CRH's ability to make acquisitions caused by their negative share price momentum?

Q: If you own shares in VSN now,should one hold or sell at 18.65?

Q: Which stock would be your choice at today's valuations, $bep.u or $bip.un?

Thanks Valter

Q: What is your opinion on Cbl at these levels?
Or would you recommend another company in this space?

Q: May I have your thoughts wrt to their earnings and their potential going forward? Hold or buy?

Thanks for your great service!

Q: Nice unexpected lift today from Agnico Eagle. Can you comment on their results?